VALORANT Champions Tour 2022: Korea Stage 1 Challengers
Quarterfinals
Jeux
Jeu 1
Ascent
Jeu 2
Bind
kda
+/-
ACS
Clas. 3.0
KAST
ADR
hs%
Impact
fk
fd
F+/-
mk
Éch.
Embr.
39 / 23 / 14
+16
227.72
1.27
85.65%
153.44
25%
39
1
1
0
-
-
-
36 / 29 / 10
+7
231.26
1.17
67.51%
154.00
25%
295
8
10
-2
-
-
-
32 / 29 / 13
+3
216.42
1.07
76.77%
133.16
31%
300
9
4
+5
-
-
-
28 / 32 / 26
-4
206.91
0.98
81.81%
142.72
26%
161
5
-
+5
-
-
-
28 / 34 / 17
-6
197.40
0.88
72.28%
135.88
32%
106
3
2
+1
-
-
-
kda
+/-
ACS
Clas. 3.0
KAST
ADR
hs%
Impact
fk
fd
F+/-
mk
Éch.
Embr.
46 / 29 / 8
+17
311.42
1.37
74.74%
201.86
35%
38
1
1
0
-
-
-
28 / 33 / 20
-5
193.42
0.94
79.16%
126.44
18%
116
3
3
0
-
-
-
26 / 32 / 13
-6
180.23
0.90
69.72%
125.23
31%
169
5
9
-4
-
-
-
25 / 38 / 6
-13
168.77
0.74
71.91%
103.30
19%
131
4
4
0
-
-
-
22 / 32 / 16
-10
142.19
0.70
60.40%
85.86
25%
154
4
9
-5
-
-
-
Bookmaker
Dplus
vs
HolyMolly
Matchs passés
Date
Match
Événement
Matchs passés
Date
Match
Événement
2022-03-10 10:50:00
HolyMolly
0
-
2
DRX
VALORANT Champions Tour 2022: Korea Stage 1 Challengers
2022-03-05 09:35:00
HolyMolly
2
-
1
WGS
VALORANT Champions Tour 2022: Korea Stage 1 Challengers
2022-03-03 07:00:00
HolyMolly
0
-
2
Team T5
VALORANT Champions Tour 2022: Korea Stage 1 Challengers
2022-03-02 07:05:00
HolyMolly
1
-
2
Maru G
VALORANT Champions Tour 2022: Korea Stage 1 Challengers
2022-02-26 07:00:00
HolyMolly
1
-
2
Sla2ers
VALORANT Champions Tour 2022: Korea Stage 1 Challengers
2022-02-24 07:00:00
HolyMolly
0
-
2
Dplus
VALORANT Champions Tour 2022: Korea Stage 1 Challengers
Face à face
MVP
Informations sur l'événement
VALORANT Champions Tour 2022: Korea Stage 1 Challengers
2022-02-23 00:00:00
-
2022-03-27 00:00:00
38
Matchs
$85,688
Cagnotte
A-Tier
Niveau
Dernières nouvelles
Nongshim RedForce battent Gen.G Esports
21 hours ago
Rex Regum Qeon signent natz
1 day ago
Wolves Esports ne passent pas en play-off VCT 2025: China Stage 2
2 days ago
ZETA DIVISION battent les champions Masters Toronto
4 days ago
G2 Esports avec difficulté mais continuent leur chemin vers le sommet
5 days ago
MIBR montrent leur ancienne forme
5 days ago